IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Biomark Capital Management Co. LLC

Q1 2017 Holdings

Filed 2017-05-11 | 3 holdings | $7.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Adma Biologics, Inc.(ADMA)COM000899104$7.0M1,433,30499.3%
Juno Therapeutics, Inc.COM48205A109$48.1K2,168,6010.7%
Mabvax Therapeutics Holdings, Inc.COM NEW55414P504$6126,7080.0%